References:
1.  WHO. Coronavirus disease (COVID-19) outbreak. https://www.who.int/emergencies/diseases/novel-coronavirus-2019.
2. Valdés-Florido MJ, López-Díaz Á, Palermo-Zeballos FJ, Martínez-Molina I, Martín-Gil VE, Crespo-Facorro B, et al. Reactive psychoses in the context of the COVID-19 pandemic: Clinical perspectives from a case series. Rev Psiquiatr Salud Ment. 2020;13(2):90‑4.
3. Henske EP, Jóźwiak S, Kingswood JC, Sampson JR, Thiele EA. Tuberous sclerosis complex. Nat Rev Dis Primer. 26 mai 2016;2(1):1‑18.
4. Northrup H, Krueger DA. Tuberous Sclerosis Complex Diagnostic Criteria Update: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference. Pediatr Neurol. oct 2013;49(4):243‑54.
5. de Vries PJ, Whittemore VH, Leclezio L, Byars AW, Dunn D, Ess KC, et al. Tuberous sclerosis associated neuropsychiatric disorders (TAND) and the TAND Checklist. Pediatr Neurol. janv 2015;52(1):25‑35.
6. Leclezio L, de Vries PJ. Advances in the treatment of tuberous sclerosis complex. Curr Opin Psychiatry. mars 2015;28(2):113‑20.
7. Varghese JJ, Thomas SP, Kallivayalil RA. Tuberous sclerosis: its neurological and neuropsychiatric aspects and a case report. Kerala Journal of Psychiatry. 2018;31(1).
8. Curatolo P, Moavero R, de Vries PJ. Neurological and neuropsychiatric aspects of tuberous sclerosis complex. Lancet Neurol. juill 2015;14(7):733‑45.
9. Kingswood JC, d’Augères GB, Belousova E, Ferreira JC, Carter T, Castellana R, et al. TuberOus SClerosis registry to increase disease Awareness (TOSCA) – baseline data on 2093 patients. Orphanet J Rare Dis. 5 janv 2017;12(1):2.
10. Clancy MJ, Clarke MC, Connor DJ, Cannon M, Cotter DR. The prevalence of psychosis in epilepsy; a systematic review and meta-analysis. BMC Psychiatry. 13 mars 2014;14(1):75.
11. Kanner AM, Rivas-Grajales AM. Psychosis of epilepsy: a multifaceted neuropsychiatric disorder. CNS spectrums. 2016 Jun;21(3):247-57.
12. Ilanković AN, Ilanković NN. Tuberous sclerosis epilepsy and psychosis by adults. Ment Health. 2019;14:819-20.
13. Brooks SK, Webster RK, Smith LE, Woodland L, Wessely S, Greenberg N, Rubin GJ. The psychological impact of quarantine and how to reduce it: rapid review of the evidence. The lancet. 2020 Mar 14;395(10227):912-20.
14. Fusar‐Poli P, McGorry PD, Kane JM. Improving outcomes of first-episode psychosis: an overview. World Psychiatry. 2017;16(3):251‑65.
15. Fierini F, Moretti D, Ballerini A. Psychosis spectrum disorders during and after the COVID-19 pandemic: Warning signs of « stress incubation ». Psychiatry Res. 2020;291:113291.
16. Yao H, Chen J-H, Xu Y-F. Patients with mental health disorders in the COVID-19 epidemic. Lancet Psychiatry. 2020;7(4):e21.
17. Sedky K, Hughes T, Yusufzie K, Lippmann S. Tuberous sclerosis with psychosis. Psychosomatics. déc 2003;44(6):521‑2.